Mark Suett

4PUBLICATIONS
7CO-AUTHORS
Pharmaceutical delivery technologiesPharmacology and pharmaceutical sciences not elsewhere classifiedInformation systems user experience design and developmentHypersonic propulsion and hypersonic aerothermodynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2026
Patient and Healthcare Professional Attitudes and Trial Experiences with a Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) for Schizophrenia Treatment.

|May 14, 2026
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm.

|Oct 24, 2024
Introducing S.C.O.P.E.™ (Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement), an Interactive Digital Platform to Educate Healthcare Professionals on Schizophrenia Care.

Christoph U Correll, Jose M Rubio, Leslie Citrome

|Oct 14, 2024
TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia.

Leslie Citrome, Mark Suett, Kelli R Franzenburg

Pageof 1

Frequent Collaborators

3 joint publications

Leslie Citrome

2 joint publications

John M Kane

2 joint publications

Christoph U Correll

1 joint publications

Kelli R Franzenburg